COMP <GO>
ROIV vs ZTS // FREE CASH FLOW YIELD
Roivant Sciences Ltd. (NASDAQ) VS. Zoetis Inc. (NYSE) • 15-METRIC TALLY: ROIV 2
— ZTS 9
▲ FREE CASH FLOW YIELD LEADER: ZTS
LAST: $35.89 (-2.76%) • MKT CAP: $26.66B
fcf-yield
-2.80%
LAST: $83.18 (+4.34%) • MKT CAP: $32.94B
fcf-yield
7.01%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ROIV VS. ZTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ROIV | ZTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 71.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -14.00% | 25.70% | -39.70 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 10.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -2.80% | 7.01% | -9.81 | ZTS | /fcf-yield <GO> |
| Operating Margin | -60.00% | 34.40% | -94.40 | ZTS | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 28.20% | -88.20 | ZTS | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 2.30% | -67.30 | ZTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 4.53 | +21.47 | ROIV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | ZTS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.3 | 59.6 | -6.30 | ZTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.99 | +0.01 | ROIV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 11.3x | +16.70 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $26.66B | $32.94B | -$6.28B | ZTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ROIV REV | ZTS REV | ROIV GROSS % | ZTS GROSS % | ROIV FCF | ZTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.3M | $9.47B | — | 71.8% | -$758.6M | $2.28B |
| FY 2024 | $29.1M | $9.26B | — | 70.6% | -$844.0M | $2.30B |
| FY 2023 | $32.7M | $8.54B | — | — | -$766.7M | $1.97B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ROIV // BETA 1.00
ZTS // BETA 0.99